PRA Health Sciences (PRAH) Tops Q3 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences, Inc. Reports Third Quarter 2018 Results and Updates 2018 Guidance
October 31, 2018 4:40 PM EDTNet new business of $657.2 million; Net book-to-bill of 1.28
$717.6 million of revenue; 23.3% growth at actual foreign exchange rates and 24.0% growth on a constant currency basis
$572.9 million of revenue excluding the impact of ASC 606; 15.8% growth at actual foreign exchange rates; 16.3% growth on a constant currency basis
GAAP net income per diluted share of $0.02 and GAAP net income of $1.5 million
Adjusted net income per diluted share was $1.13 and adjusted net income was $74.8 million
Maintaining 2018 revenue guidance between... More
